FFA
AURA icon

Farther Finance Advisors’s Aura Biosciences AURA Stock Holding History

Farther Finance Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
434
+426
+5,325% +$3.05K ﹤0.01% 5014
2026
Q1 		$54 Sell
8
-86
-91% -$494 ﹤0.01% 5566
2025
Q4 		$512 Hold
94
– – ﹤0.01% 5050
2025
Q3 		$581 Buy
+94
New +$615 ﹤0.01% 4502

Other funds holding AURA

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Farther Finance Advisors's AURA Position: Q2 2026 in Review

Farther Finance Advisors increased its Aura Biosciences (AURA) stake by 5,325% in Q2 2026, buying an estimated $3.05K and bringing the position to 434 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5014.

Farther Finance Advisors first reported a position in AURA in Q3 2025 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Farther Finance Advisors held 434 shares of Aura Biosciences worth $3.08K as of Q2 2026.
  • Farther Finance Advisors bought 426 Aura Biosciences shares in Q2 2026, an estimated $3.05K.
  • Aura Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5014 holding.
  • Farther Finance Advisors first reported a position in Aura Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 16 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.